Avvisa Approves Registration of Five New Slimming Pens; See List

Globo

Lean Right

Factuality

Ownership

The National Agency of Health Surveillance approved, on Wednesday, five new semiglutide-based pens in Brazil after the end of the patent of the molecule in the country. All received the endorsement for the treatment of type 2 diabetes, with doses of up to 1.34 mg/mL. In all, six medicines of the type have been released by the health agency since the end of the license, in March. The approved pens were: Semavy - from Cosmed Cosmetics and Medicine…

CNN Brasil

Factuality

Ownership

Active principle is used for the treatment of diabetes and weight loss on medical recommendation

A TARDE

Factuality

Ownership

The National Agency for Health Surveillance (Anvisa) authorised the registration of five new medicines based on semaglutide, an active principle used in the treatment of type 2 diabetes and obesity. The decision was published in the Official Journal of the Union on Wednesday, 29.According to the resolution of the General Management of Drugs of Anvisa, all products were registered in the category of "new medicine (analog new IFA) by way of abbrev…

Metrópoles

Factuality

Ownership

New devices, known as slimming pens, have been authorised to supplement diet and exercise